Lyceum Society November 2022 Meeting
Monday, November 7, 2022
Social Time and Announcements: 11:30 am to 11:45 am
Initial Presentation: 11:45 am to 12:30 pm
Speaker: Dr. Jeanie S. Payne
Topic: Microbiology Laboratory Manual for Nursing and Allied Health Students: The Application of the Laboratory Exercises
The Question: How do we use these laboratory exercises to make them relevant in clinical situations? One way to make them relevant to the microbiology student is to introduce case studies in the clinical microbiology laboratory. This encourages inductive thinking which requires collecting, organizing and manipulating data. Microbiology lectures and laboratories already support inductive thinking skills. Therefore, using case studies can expand the critical thinking skill component in the microbiology laboratory.
This presentation will include the following:
- A view of the laboratory manual
- A view of the laboratory exercises
- Two examples of case studies
- Sample case study questions
Dr. Jeanie S. Payne received her B.A. Degree from Lehman College in Biology with a minor in Chemistry in 1973. She also received an M.S. Degree from Wagner College in Bacteriology and Public Health, in 1976. Dr. Payne received another Masters’ degree (M.Ed.) and her Doctoral Degree (Ed.D.) in Microbiology and Science Education from Columbia University/Teachers College from 1980-1984. She also taught Science at Epiphany Lutheran High School (Biology, Chemistry, General Science and Physics), where she was the chairperson of the Science Department from 1978-1984, while working on her doctorate.
Dr. Payne taught Clinical Microbiology to Nursing and Allied Health students at Bergen Community College in Paramus New Jersey for 27 years in the Biology Department, Division of STEM from 1989-2016. During her sabbatical (1999-2000) she received a Mid-Career Fellowship from Princeton University and in 2000 published a paper titled “The Use of Case Studies in the Microbiology Experience”. She became a Full Professor in 2002. She co-authored a microbiology laboratory manual that was published in 2003 and is still being used in the labs at Bergen Community College. She retired in 2016 and was awarded Professor Emerita in 2017. Dr. Payne continues to do her own research working with yeast cells at Columbia University, where she maintains a lab. She also consults with colleagues and gives short lectures about COVID as one of the members of the Health Team at Epiphany Lutheran Church.
Main Presentation: 12:30 pm to 2:15pm
Speaker: Dr. Charles B. Simone
Topic: The Role of Radiation Oncology in the Current and Future Cancer Therapy Landscape
Radiation therapy is one of the three primary pillars of modern cancer treatment, along with surgery and systemic therapy. Radiation therapy is a critical treatment for most solid malignancies that are localized at presentation, and it is delivered in these cases with curative intent, often in combination with surgery and systemic therapy. Radiation therapy also has important roles for patients with metastatic disease, most commonly to palliate or prevent quality-of-life-limiting symptoms, but increasingly also to provide durable local control and improved clinical outcomes for patients with oligometastatic or oligoprogressive disease.
Radiation therapy is most commonly delivered with photon therapy. Intensity-modulated radiation therapy has allowed for improved treatment delivered over older photon treatment modalities. Proton therapy is increasingly being delivered and can often better spare normal tissues adjacent to the tumor from unnecessary irradiation and the resulting side effects of that irradiation. Increased precision of radiotherapy delivery has been enabled by increased utilization of and improvements in advanced imaging modalities and daily image guidance. While most irradiation is delivered daily for several weeks and achieves tumor control by forming double stranded DNA breaks in tumor cells, stereotactic radiosurgery and stereotactic body radiation therapy are increasingly being used and are able to ablate tumors, allowing for increased treatment efficacy. Optimizing the synergy between radiation therapy and immunotherapy and exploiting the delivery of ultra-high dose rate radiation therapy (FLASH) both show promise in furthering the role of radiation oncology in the cancer treatment landscape.
Dr. Charles B. Simone, II, MD, FACRO is Research Professor and Chief Medical Officer of the New York Proton Center and Full Member in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center. He is an internationally recognized expert in using proton therapy to treat thoracic malignancies and for reirradiation, and in developing clinical trials and innovative research in thoracic oncology and stereotactic body radiation therapy. Prior to coming to NYPC, Dr. Simone was Chief of the Thoracic Oncology Service at the Hospital of the University of Pennsylvania, Director of the Penn Mesothelioma and Pleural Program, and Director of Clinical Research and Operations in the Department of Radiation Oncology at Penn. He was then appointed Medical Director of the Maryland Proton Treatment Center, and at University of Maryland, he also served as Chair of the Clinical Research Committee for their Comprehensive Cancer Center, proton therapy Fellowship Director, and Director of the Stereotactic Radiation Therapy Program. He completed his undergraduate and medical school training at University of Pennsylvania and residency in radiation oncology at the National Cancer Institute (NCI), NIH, where he served as chief resident.
Dr. Simone is a National Institutes of Health, National Science Foundation, and Department of Defense funded investigator who has published >475 scientific articles and chapters, given >395 scientific lectures to national/international audiences, and is the national Principal Investigator or Co-Chair of 8 NIH-funded cooperative group trials (5 NRG Oncology, 1 SWOG, 1 ECOG-ACRIN, 1 PCG). He is a three-time Association of Residents in Radiation Oncology Educator of the Year Award winner, and he has been elected for Fellowship in the American College of Radiation Oncology (FACRO). Dr. Simone is the Proton Collaborative Group (PCG) Board President. He Chairs the American Society for Radiation Oncology (ASTRO) Lung Resource Panel Committee, ASTRO Blue Ribbon Lung Panel, NRG Oncology Particle Therapy Work Group, PCG Lung Committee, American Radium Society (ARS) Appropriate Use Criteria Thoracic Committee, American College of Radiation Oncology (ACRO) Annual Meeting Abstracts Committee, NCI/Radiosurgery Society GRID-Lattice-Microbeam-Flash Radiotherapy Clinical Working Group, Varian FlashForward Consortium Clinical Committee, and multiple Particle Therapy Co-Operative Group (PTCOG) subcommittees. He is Editor-in-Chief of Annals of Palliative Medicine and on the Editorial Boards of Translational Lung Cancer Research, Frontiers in Oncology, Cancers, Journal of Thoracic Disease, Annals of Translational Medicine, and Therapeutic Radiology and Oncology, among others.